Zydus Lifesciences has signed an MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) blood test across India. Designed for individuals aged 45 and above, the test screens for 10 common cancers through a single blood sample. The test has also received FDA Breakthrough Device Designation.